Mental Process – Page 2

Novavaxs held-up approval package may signal warning for Covid vaccine makers

2 months ago talkbio0Tagged Approved, COVID19 (disease), Deferred, Maker (occupation), Market, Novavax 's, United States Food and Drug Administration, Vaccines

Vaccines, Approved, COVID19 (disease), United States Food and Drug Administration, Market, Novavax ‘s, Maker (occupation), Deferred

Lilly continues full-court press against breast cancer with women’s March Madness event sponsorships

2 months ago talkbio0Tagged Awareness, Basketball game, Eli Lilly, Event, Madness, Malignant neoplasm of breast, Woman

Eli Lilly, Woman, Madness, Malignant neoplasm of breast, Event, Awareness, Basketball game

Patient suffers side effect in Cabaletta autoimmune CAR-T trial, but analysts unfazed

2 months ago talkbio0Tagged Adverse effects, analysts, aspects of adverse effects, Autoimmune Diseases, Cabaletta, CAR-T therapy, cell-associated neurotoxicity, Cytokine Release Syndrome, Lupus Erythematosus, Systemic, reSET (device), Systemic Scleroderma

Systemic Scleroderma, Lupus Erythematosus, Systemic, Cabaletta, cell-associated neurotoxicity, Adverse effects, analysts, Autoimmune Diseases, CAR-T therapy, reSET (device), aspects of adverse effects, Cytokine Release Syndrome

Solbinsiran: Eli Lilly’s Promising ANGPTL3 Inhibitor for Lipid Management

2 months ago talkbio0Tagged ANGPTL3, Dyslipidemias, Lipids, Psychological inhibition, RNA, Small Interfering, solbinsiran

ANGPTL3 inhibition, solbinsiran, dyslipidemia, lipid reduction, siRNA therapy

Beyond Black Box: How Data-Driven AI Is Transforming RNA Medicine Development

2 months ago talkbio0Tagged Aortic Valve Insufficiency, black box, Clinical Trials, Data-Driven AI, datasets, development aspects, Drug Design, RNA medicine, Transforming RNA Medicine Development

Aortic Valve Insufficiency, development aspects, RNA medicine, black box, Data-Driven AI, Transforming RNA Medicine Development, datasets, Drug Design, Clinical Trials